Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis
- 1 August 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 89 (2), 161-168
- https://doi.org/10.1016/0002-9343(90)90294-n
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: Clinical and in vitro studiesArthritis & Rheumatism, 1989
- Formal education level as a significant marker of clinical status in rheumatoid arthritisArthritis & Rheumatism, 1988
- Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemiaArthritis & Rheumatism, 1988
- Treatment of the Anemia of Predialysis Patients with Recombinant Human Erythropoietin: A Randomized, Placebo-Controlled TrialThe Lancet Healthy Longevity, 1988
- Blunted erythropoietin response to anaemia in rheumatoid arthritisBritish Journal of Haematology, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Erythropoietin in Patients with Anaemia in Rheumatoid ArthritisScandinavian Journal of Haematology, 1979
- Hematologic abnormalities in rheumatoid arthritisSeminars in Arthritis and Rheumatism, 1972
- 1958 Revision of diagnostic criteria for rheumatoid arthritisArthritis & Rheumatism, 1959